Dr. Evamaria Anvari, MD

Dr. Anvari practices at U.S. Renal Care Northeast Phoenix Dialysis in Phoenix, Arizona.

Dr. Anvari's NPI, 1558524330, was assigned on July 2, 2008. Dr. Anvari holds Arizona license 45009.

Dr. Anvari's primary practice is U.S. Renal Care Northeast Phoenix Dialysis, at 3305 East Greenway Road, Suite 1, Phoenix, AZ 85032 in Maricopa County. The practice phone is (214) 736-2700.

Dr. Anvari's primary practice is U.S. Renal Care Northeast Phoenix Dialysis in Phoenix, Arizona. Dr. Anvari is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Anvari to 4 more dialysis centers and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anvari practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Anvari's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Anvari's licenses on file in 2 states: Arizona and Ohio.

CMS data shows 11,834 Medicare services from Dr. Anvari across 24 procedure codes in 2024, for 626 Medicare patients. Medicare paid $131,390 for them.

CMS counts 626 Medicare patients who saw Dr. Anvari in 2024. The largest group is 75 to 84, with 250 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 4.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anvari's median patient age at 64, with 38% women.

In 2024, Dr. Anvari wrote 644 Medicare Part D claims for 129 patients. 91% of them were for generic drugs. CMS names the drug for 481 of them, across 22 drugs with 11 or more claims each, at $29,079 in total drug cost. In 2023, CMS named 629 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Anvari for performance year 2024, reported as part of a group. Dr. Anvari accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anvari as offering telehealth.

Dmand AI links 8 papers to Dr. Anvari, published from 2020 to 2023. 2021 was the busiest year, with 3. Dr. Anvari has published most often in Kidney Int Rep. Dr. Anvari's most frequent co-authors are Tushar Jitendra Vachharajani, MD, Mohamed Hassanein, MD and Yeshwanter Radhakrishnan, MD.

CMS Open Payments shows 41 general payments to Dr. Anvari from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 63% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,697.